Literature DB >> 27187849

Cytokine Patterns in Healthy Adolescent Girls: Heterogeneity Captured by Variable and Person-Centered Statistical Strategies.

Lorah D Dorn1, Jochebed G Gayles, Christopher G Engeland, Renate Houts, Giovanni Cizza, Lee A Denson.   

Abstract

BACKGROUND: Little is known about variation in individual cytokines/cytokine profiles for a large healthy, pediatric population. When cytokines in a healthy group are not abnormally high as in a disease state, it is challenging to determine appropriate statistical strategies. The aims of the study were (1) to describe variation among cytokine concentrations and profiles in healthy adolescent girls, (2) to illustrate utility of data reduction approaches novel to cytokine research, (variable-centered [principal factor analysis, PFA], person-centered [latent profile analysis, LPA]), and (3) to demonstrate utility of such methods in linking cytokine profiles to health outcomes (e.g., depressive, anxiety symptoms).
METHOD: Serum was analyzed for 13 cytokines representing adaptive and innate immune responses in 262 girls (age = 11, 13, 15, and 17 years).
RESULTS: There was great variation in cytokine concentrations. PFA revealed a four-factor solution explaining 73.13% of the shared variance among 13 cytokines (e.g., factor 1 included interleukin [IL]-4, IL-13, IL-5, interferon gamma; 26.65% of the shared variance). The LPA supported classifying girls into subgroups characterized by "high overall" (7.3% of sample), "high adaptive" (26.7%), "high innate" (21%), or "low overall" (45%) cytokine levels. Factors and profiles were useful in describing individual differences in depressive/anxiety symptoms (e.g., factor 1 positively associated with depressive symptoms but negatively with trait anxiety; increased depressive symptoms or trait anxiety was associated with greater likelihood of being in the "high adaptive" group).
CONCLUSIONS: Healthy girls showed differences in cytokine levels and patterns of variation and important associations with psychological variables. PFA and LPA offer novel approaches useful for examining cytokine panels in healthy populations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27187849      PMCID: PMC4927350          DOI: 10.1097/PSY.0000000000000321

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  21 in total

1.  Age, cohort, and time development muddles: easy in practice, hard in theory.

Authors:  G Donaldson; J L Horn
Journal:  Exp Aging Res       Date:  1992 Autumn-Winter       Impact factor: 1.645

2.  Investigating population heterogeneity with factor mixture models.

Authors:  Gitta H Lubke; Bengt Muthén
Journal:  Psychol Methods       Date:  2005-03

3.  Bone mass, depressive, and anxiety symptoms in adolescent girls: variation by smoking and alcohol use.

Authors:  Lorah D Dorn; Stephanie Pabst; Lisa M Sontag; Heidi J Kalkwarf; Jennifer B Hillman; Elizabeth J Susman
Journal:  J Adolesc Health       Date:  2011-05-28       Impact factor: 5.012

4.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

5.  Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay.

Authors:  Michael R Pranzatelli; Elizabeth D Tate; Nathan R McGee; Jerry A Colliver
Journal:  J Interferon Cytokine Res       Date:  2013-05-09       Impact factor: 2.607

6.  Age-dependent levels of select immunological mediators in sera of healthy children.

Authors:  U Sack; U Burkhardt; M Borte; H Schädlich; K Berg; F Emmrich
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 7.  New players in the cytokine orchestra of inflammatory bowel disease.

Authors:  Massimo C Fantini; Giovanni Monteleone; Thomas T Macdonald
Journal:  Inflamm Bowel Dis       Date:  2007-11       Impact factor: 5.325

8.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Authors:  John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

Review 9.  Cytokines and other immunological biomarkers in children's environmental health studies.

Authors:  Paurene Duramad; Ira B Tager; Nina T Holland
Journal:  Toxicol Lett       Date:  2007-05-25       Impact factor: 4.372

10.  Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

Authors:  Aruna D Pradhan; JoAnn E Manson; Jacques E Rossouw; David S Siscovick; Charles P Mouton; Nader Rifai; Robert B Wallace; Rebecca D Jackson; Mary B Pettinger; Paul M Ridker
Journal:  JAMA       Date:  2002-08-28       Impact factor: 56.272

View more
  9 in total

1.  Interleukin-4 signalling pathway underlies the anxiolytic effect induced by 3-deoxyadenosine.

Authors:  Tangxin Gao; Bai Li; Yangyang Hou; Shaolei Luo; Lei Feng; Jun Nie; Yi Ma; Le Xiao; Xu Chen; Hongkun Bao; Xianmin Lu; Feilong Huang; Gang Wang; Chunjie Xiao; Jing Du
Journal:  Psychopharmacology (Berl)       Date:  2019-04-08       Impact factor: 4.530

2.  Negative and positive affect as predictors of inflammation: Timing matters.

Authors:  Jennifer E Graham-Engeland; Nancy L Sin; Joshua M Smyth; Dusti R Jones; Erik L Knight; Martin J Sliwinski; David M Almeida; Mindy J Katz; Richard B Lipton; Christopher G Engeland
Journal:  Brain Behav Immun       Date:  2018-09-11       Impact factor: 7.217

3.  Inflammation and depression in young people: a systematic review and proposed inflammatory pathways.

Authors:  Yara J Toenders; Liliana Laskaris; Christopher G Davey; Michael Berk; Yuri Milaneschi; Femke Lamers; Brenda W J H Penninx; Lianne Schmaal
Journal:  Mol Psychiatry       Date:  2021-10-11       Impact factor: 15.992

4.  Affect variability and inflammatory markers in midlife adults.

Authors:  Dusti R Jones; Joshua M Smyth; Christopher G Engeland; Martin J Sliwinski; Michael A Russell; Nancy L Sin; David M Almeida; Jennifer E Graham-Engeland
Journal:  Health Psychol       Date:  2020-04-23       Impact factor: 5.556

5.  Influence of Age and Other Factors on Cytokine Expression Profiles in Healthy Children-A Systematic Review.

Authors:  Marie-Luise Decker; Martin P Grobusch; Nicole Ritz
Journal:  Front Pediatr       Date:  2017-12-14       Impact factor: 3.418

6.  Identification of inflammatory markers suitable for non-invasive, repeated measurement studies in biobehavioral research: A feasibility study.

Authors:  H M Schenk; S L van Ockenburg; M C Nawijn; P De Jonge; J G M Rosmalen
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

7.  Individuals with both higher recent negative affect and physical pain have higher levels of C-reactive protein.

Authors:  Jennifer Graham-Engeland; Natasha N DeMeo; Dusti R Jones; Ambika Mathur; Joshua M Smyth; Martin J Sliwinski; Megan E McGrady; Richard B Lipton; Mindy J Katz; Christopher G Engeland
Journal:  Brain Behav Immun Health       Date:  2022-02-15

8.  Cytokine alterations in pediatric internalizing disorders: Systematic review and exploratory multi-variate meta-analysis.

Authors:  Aaron S Howe; David A Lynch
Journal:  Brain Behav Immun Health       Date:  2022-07-16

9.  Vitamin D Status and Immune Health Outcomes in a Cross-Sectional Study and a Randomized Trial of Healthy Young Children.

Authors:  Neil R Brett; Paula Lavery; Sherry Agellon; Catherine A Vanstone; Susan Goruk; Catherine J Field; Hope A Weiler
Journal:  Nutrients       Date:  2018-05-27       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.